Clinical Amyloid Typing by Proteomics: Performance Evaluation and Data Sharing between Two Centres
Amyloidosis is a relatively rare human disease caused by the deposition of abnormal protein fibres in the extracellular space of various tissues, impairing their normal function. Proteomic analysis of patients’ biopsies, developed by Dogan and colleagues at the Mayo Clinic, has become crucial for cl...
Main Authors: | Diana Canetti, Francesca Brambilla, Nigel B. Rendell, Paola Nocerino, Janet A. Gilbertson, Dario Di Silvestre, Andrea Bergamaschi, Francesca Lavatelli, Giampaolo Merlini, Julian D. Gillmore, Vittorio Bellotti, Pierluigi Mauri, Graham W. Taylor |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/7/1913 |
Similar Items
-
The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis
by: Tamer Rezk, et al.
Published: (2019-07-01) -
Fungal Secretome for Biorefinery: Recent Advances in Proteomic Technology
by: Adav, Sunil S., et al.
Published: (2016) -
The Protein Network in Subcutaneous Fat Biopsies from Patients with AL Amyloidosis: More Than Diagnosis?
by: Dario Di Silvestre, et al.
Published: (2023-02-01) -
Immature Seed Endosperm and Embryo Proteomics of the Lotus (Nelumbo Nucifera Gaertn.) by One-Dimensional Gel-Based Tandem Mass Spectrometry and a Comparison with the Mature Endosperm Proteome
by: Carlo F. Moro, et al.
Published: (2015-08-01) -
Exploration of human cerebrospinal fluid: A large proteome dataset revealed by trapped ion mobility time-of-flight mass spectrometry
by: Charlotte Macron, et al.
Published: (2020-08-01)